D.C. Mun. Regs. tit. 22, r. 22-C5615

Current through Register Vol. 71, No. 52, December 27, 2024

Rule 22-C5615 - SEED-TO-SALE TRACKING SYSTEM

5615.1

The Board may require a dispensary, cultivation center, and testing laboratory to purchase and participate in a seed-to-sale tracking system as determined by the Board for purposes of:

(a) Tracking, in real-time, all medical marijuana plants and products from cloning or seed through cultivation, testing, transportation, and sale or destruction;

(b) Tracking and verifying all purchases and sales; and

(c) Tracking and verifying all District of Columbia and non-resident patient purchases to confirm and ensure the identity of the patients, the validity of the patient's authorization to purchase, and ensuring that the patients do not purchase more than four ounces within a thirty day period.

D.C. Mun. Regs. tit. 22, r. 22-C5615

Source: Notice of Emergency and Third Proposed Rulemaking published at 58 DCR 3299 (April 15, 2011)[EXPIRED]; as amended by Notice of Emergency and Fourth Proposed Rulemaking published at 58 DCR 7207 (August 12, 2011)[EXPIRED]; as amended by Notice of Final Rulemaking published at 58 DCR 10128, 10208 (December 2, 2011); amended by Final Rulemaking published at 66 DCR 10217 (8/9/2019); amended by Final Rulemaking published at 71 DCR 2388 (3/8/2024)

Authority: The Mayor, pursuant to section 14 of the Legalization of Marijuana for Medical Treatment Initiative of 1999 (Act), effective July 27, 2010 (D.C. Law 18-210; D.C. Official Code §§ 7-1671.01, et. seq. (2011 Supp.)).